Loading clinical trials...
Loading clinical trials...
A Prospective Randomized Trial of 2 Weeks vs 3 Months of Antibiotics Post Percutaneous Nephrolithotomy for the Prevention of Infection-Related Kidney Stones
Conditions
Interventions
ciprofloxacin, cotrimoxazole-trimethoprim, macrodantin
Locations
12
United States
Mayo Clinic - Scottsdale/Phoenix, AZ
Scottsdale, Arizona, United States
University California San Diego
San Diego, California, United States
Johns Hopkins University
Baltimore, Maryland, United States
Harvard University - Massachusetts General Hospital
Boston, Massachusetts, United States
Mayo Clinic - Rochester, MN
Rochester, Minnesota, United States
Dartmouth University
Lebanon, New Hampshire, United States
Start Date
March 1, 2015
Primary Completion Date
December 1, 2023
Completion Date
December 1, 2023
Last Updated
May 17, 2022
NCT07055282
NCT07174479
NCT07173309
NCT06898216
NCT07159503
NCT07155005
Lead Sponsor
University of British Columbia
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions